Oxytocin Research Peptide Overview

Oxytocin is a cyclic nonapeptide hormone produced in the hypothalamic paraventricular and supraoptic nuclei and released from the posterior pituitary. This research peptide activates the oxytocin receptor (OXTR), a Gq-coupled GPCR, and is studied in preclinical models of social behavior neurobiology, neuroendocrine regulation, and reproductive physiology.

What Is Oxytocin?

Oxytocin (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2) was the first polypeptide hormone to be chemically synthesized, accomplished by Vincent du Vigneaud in 1953. The peptide forms a six-amino acid disulfide ring connected to a three-residue tail. Oxytocin acts through the OXTR, which couples to Gq/11 to activate PLC, IP3, and intracellular calcium signaling. In the CNS, oxytocin modulates social behavior, pair bonding, trust, and anxiety-like behaviors through effects on amygdala, hippocampus, and prefrontal cortex circuits. Peripherally, oxytocin stimulates uterine smooth muscle contraction and mammary gland myoepithelial cell activity. Published research has established oxytocin’s role in social cognition through modulation of GABAergic interneurons in the hippocampus and suppression of amygdala fear responses (Donaldson & Young, Science, 2008). The peptide’s dual central-peripheral actions make it essential for studying neuroendocrine integration.

Oxytocin Mechanism of Action in Research

Oxytocin binds the OXTR, activating Gq/11-mediated PLC/IP3/calcium signaling. In neurons, calcium mobilization modulates neurotransmitter release and synaptic plasticity. Oxytocin enhances GABAergic inhibition in the hippocampus, modulates amygdala reactivity, and influences dopaminergic signaling in reward circuits. In peripheral tissues, calcium-dependent smooth muscle contraction occurs through myosin light chain kinase activation. Oxytocin also demonstrates autocrine and paracrine signaling within the hypothalamus, amplifying its own release through positive feedback mechanisms.